Magazine

CVCs poised to benefit from positive momentum

27th July 2021

James Mawson

The effective equality between public and private capital markets is almost complete.

The documentation of inventions during spinout

27th July 2021

Mark Lubbock and Zachary Hyde, partners, Brown Rudnick

Careful documentation of inventive activity during the early stages of a spinout are important to avoid legal complications.

Albotherm seeds a green future

27th July 2021

Thierry Heles

Based on research at University of Bristol, Albotherm’s technology could revolutionise how greenhouses and buildings are cooled.

TenU Hosts Regional Opportunities: four key messages

27th July 2021

Ananay Aguilar, policy adviser to TenU

George Baxter of Edinburgh Innovations chaired TenU’s fourth event, leading a discussion on growing regional innovation hubs.

Isolere Bio breaks the biomanufacturing bottleneck

27th July 2021

Thierry Heles

Co-founder and CEO Kelli Luginbuhl talks to GUV about how the Duke spinout re-imagines the manufacturing of complex biologics.

Imperial reignites funding operation

27th July 2021

Thierry Heles

The institution is starting afresh with its investment activities, having brought the management of its spinouts back in-house after Touchstone.

H1 2021: a period without precedent

27th July 2021

Thierry Heles

Investors have ploughed almost as much money into spinouts in the first six months of the year as they did for all of 2020.

Solving the quantum problem

27th July 2021

Thierry Heles

July 2021 issue editorial: Quantum computing remains an area fraught with challenges, but key breakthroughs this month show it is not out of reach.

Other News

The time is now for northern England

29th April 2021

Thierry Heles

Historically left behind by their peers in the golden triangle, universities in the north are stepping up with their own funds, accelerators and collaborations.

How Evox is engineering a new class of therapeutics

29th April 2021

Thierry Heles

Chief executive Antonin de Fougerolles talks about Evox’s journey to commercialising a new modality that could prove truly transformational.

CytoSeek chases cell therapy’s holy grail

29th April 2021

Thierry Heles

The University of Bristol spinout is working on adapting cell therapies to solid tumours.

Finding a common challenge

29th April 2021

James Mawson

The past year has shown a rapid response to global crises is possible when policymakers, universities, entrepreneurs and corporations work together.

Having an IP strategy for spinouts (and why just protecting…

29th April 2021

Mark Lubbock, partner, Brown Rudnick

Brown Rudnick partner Mark Lubbock on key issues to consider when formulating an IP strategy.

Nothing but good news

29th April 2021

Thierry Heles

A stunning three-month run for spinouts shows large sums flowing in and out of the innovation ecosystem.